U.S., Dec. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07280429) titled 'ICIAM Rehabilitation Program Study: A Randomized Controlled Trial' on Dec. 01.
Brief Summary: Immunotherapy has become a cornerstone in oncology; however, managing its associated adverse events poses a significant clinical challenge. Cardiotoxicity represents a major concern, among which myocarditis accounts for a considerable proportion. This condition is characterized by poor prognosis, highly heterogeneous outcomes, and a high prevalence of persistent cardiac dysfunction after the acute phase. The dual impact of myocardial injury and underlying malignancy severely compromises patients' quality of life. Currently, it remains uncle...